Legal Representation
Attorney
Eva Gullick Frongello
USPTO Deadlines
Next Deadline
1268 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-01-10)
Due Date
January 10, 2029
Grace Period Ends
July 10, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
13 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 10, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jan 10, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Oct 25, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Oct 25, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Oct 5, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Sep 21, 2022 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Sep 21, 2022 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Sep 21, 2022 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Sep 21, 2022 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Sep 21, 2022 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 20, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 1, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
| Feb 1, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Detailed Classifications
Class 042
Pharmaceutical research and development; research and development in pharmacology for the purpose of targeting and destroying bacteria; medical research for use in treating antibiotic-resistant bacterial infections and microbiome-related disorders; medical and scientific research; pharmaceutical research in the field of engineered bacteriophage; pharmaceutical research using engineered therapeutics for use in antibacterial drug development; pharmaceutical research, namely, research relating to engineered bacteriophage platforms for improving pharmacological properties; pharmaceutical research, namely, research relating to engineered bacteriophages for use in connection with a wide variety of therapeutic agents
First Use Anywhere:
Jun 8, 2015
First Use in Commerce:
Jan 2, 2019
Classification
International Classes
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"BIOSCIENCES"